Others have found that MyD88 inhibition via a novel inhibitor TJ-M2010-5 prevented CRC in a mouse model of colitis-associated cancer (CAC) via suppression of MDSC Arg1, iNOS and IDO expression [42]. The gene discussed is MYD88; the disease is colorectal carcinoma.